Biotherapeutics Inc cooperative finding interleukin-2 anti-cancer drug publish "New England Journal Medicine". Biotherapeutics Biological Therapy Institute National Cancer Institute publication focus reduction toxicity constant infusion mode intravenous administration protocol. Reuter 